Cancer Support Accelerator

by EVPA on February 07, 2012

A novel model combining impact investing and philanthropy in oncology
Tuesday, February 7, 2012, Zunfthaus zur Waag, Zurich, Switzerland, 8:30h until approximately 11:30h

Nextech Invest invites you to an event on 7 February in Zurich, Switzerland, to learn about the novel applied concept Cancer Support Accelerator (CSA). CSA allows combining for-profit and non-profit activities in oncology in a new and very efficient way. It greatly improves the efficiency in the fight against cancer by:

- First, increase capital available for cancer drug development through investment in outstanding and promising cancer drug development companies
- Second, allow the same funds to be used more than once
- Third, allow supporting all necessary steps from non-profit causes such as cancer prevention and cancer research all the way to funding the development of novel cancer therapies for commercialization

There are three ways to support cancer research and care with CSA:

Charity: Make a financial investment in a cancer fund that is directly investing in cancer product development

Philanthropic Donor: Donate your financial investment in a cancer fund to the charity of your choice

Philanthropic Investor: Donate 25% of your profit from investment in a cancer fund to the charity of your choice

Please find the full programme http://evpa.eu.com/wp-content/uploads/2012/01/CSA-Program-Revised.pdf